Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
5 participants
INTERVENTIONAL
2023-07-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants
NCT01349738
Asymptomatic Bacteriuria in Early Kidney Transplantation Follow up
NCT04333602
The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients
NCT02113774
Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.
NCT05597540
Urinary Tract Infections in Kidney Transplant Recipients
NCT03211026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UC Positives
Stable Transplanted Patients with Positive UC
Phage
Inserting specific specimen of phages in to the bladder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phage
Inserting specific specimen of phages in to the bladder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable Immunosupression Dose
* Stable Renal Function
* Resistant Urinary Infection with Positive UC
Exclusion Criteria
* Frail Patients
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
nooshin dalili
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dalili
Role: PRINCIPAL_INVESTIGATOR
SBMU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nooshin Dalili
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBMU-
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.